Detailed price information for Mimedx Group Inc (MDXG-Q) from The Globe and Mail including charting and trades.

Long-term heart disease risk in women diagnosed with uterine fibroids was more than 80% higher than in women without fibroids ...

For years, many healthcare executives treated claim denials as a back-office irritation—a revenue problem to be delegated, ...

The National Coalition for Assistive & Rehab Technology (NCART) will keep its core priorities intact in 2026 but plans to ...

New turnkey solution supports post-operative and wound care patients with HCPCS-compliant collagen kits and simple insurance verification* MESQUITE, Texas, Dec. 11, 2025 /PRNewswire/ -- MPM Medical , ...

InfuSystem Holdings, Inc. ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care ...

InfuSystem Holdings Inc (NYSE American:INFU) stock rose 2% in after-hours trading on Wednesday after the company announced that two of its electronic infusion pumps used in pain management have been ...

From CMS developments to device coverage, here are 10 payer updates spine surgeons should know headed into 2026: 1. Some fee-for-service spine procedures in traditional Medicare will have prior ...

The lawsuit leans on the structure of New York’s no-fault rules. GEICO cites the state’s framework for personal injury ...

The Centers for Medicare & Medicaid Services (CMS) finalized the 2026 Outpatient Prospective Payment System (OPPS) rule with a wide range of policy updates that extend beyond core payment changes. A ...

Subsidiary, Citius Oncology, launches cancer immunotherapy, LYMPHIR, in the U.S. in December 2025 CRANFORD, N.J., Dec. 23, 2025 /PRNewswire/ -- Citius Pharmaceuticals ...

Analysts might anticipate a good upside ahead for CSL shares, but I think this ASX biotech stock is a much better buy.